Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Gv 2017, L.P. investment portfolio

Gv 2017, L.P. has made numerous investments in companies such as Evox Therapeutics, Snyk, and Barinthus Biotherapeutics (Uk) within the Healthcare & Life Sciences sector.

unknown
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Barinthus Biotherapeutics (Uk) Limited
Barinthus Biotherapeutics (UK) Limited is a clinical‑stage biopharmaceutical company developing antigen‑specific immunotherapies that harness T‑cells to treat chronic viral infections, autoimmune diseases and cancer.
Healthcare & Life SciencesAltrinchamConfirmed2026-01-05
Evox Therapeutics Limited
Evox Therapeutics develops exosome‑based gene‑editing medicines that use a proprietary CRISPR editor delivered via extracellular vesicles to create safer, scalable treatments for severe neurodegenerative diseases, targeting patients with brain‑related genetic disorders.
Healthcare & Life SciencesOxfordConfirmed2026-03-16

Sign up to see the full portfolio

+1 more company

Sign up

Backs Similar Companies

Investors who tend to invest in the same sort of companies.

5 more similar investors hiddenSign up to unlock →

Shareholding changes (1)

Sign up free to see when this investor has bought or sold shares.

Sign up free